Brain Tumors

Brain tumors represent a wide spectrum of neoplasms that can originate from the brain's own structures or adjacent tissues. Depending on the type and location of the tumor, the treatment approach can vary significantly. According to the World Health Organization, primary brain tumors and central nervous system tumors are diagnosed annually in tens of thousands of patients worldwide. Timely diagnosis and access to advanced neurosurgical interventions can significantly improve prognosis and quality of life.

Diagnosis and modern treatment approach

Early and accurate diagnosis is a key factor in therapy success. The combination of high-field MRI, positron emission tomography (PET), and molecular-genetic analyses allows for determining the tumor's nature and devising an optimal treatment strategy. Methods based on neuronavigation and intraoperative visualization, which enhance the precision of surgical interventions, are becoming increasingly popular. Studies show that using intraoperative MRI allows neurosurgeons to remove the tumor with minimal impact on healthy tissues, increasing the chances of complete removal and reducing the risk of neurological complications.

Advanced neurosurgical techniques Modern neurosurgery offers a wide arsenal of solutions for treating brain tumors, among them:

• awake craniotomy: this approach ensures maximally precise preservation of important functional brain areas responsible for speech and movement.
• neuroendoscopy: minimally invasive interventions through small openings in the skull or natural anatomical paths allow for tumor removal or reduction with minimal trauma to surrounding tissues.
• radiosurgery (Gamma Knife, CyberKnife): non-invasive exposure to high doses of radiation with millimeter precision destroys tumor cells without affecting healthy structures.
• molecular-targeted therapy: individual selection of drugs based on the genetic characteristics of the tumor helps enhance treatment effectiveness and minimize side effects. Statistical data indicate significant progress in the treatment of certain types of tumors. For instance, benign meningiomas (one of the most common types of brain tumors) have a 5-year survival rate of 85–90%. New approaches to treating glioblastoma improve the median survival and enhance the quality of life for patients who, until recently, had a much less favorable prognosis.

Alisa Health Group specializes in organizing medical journeys, helping patients access cutting-edge technologies and leading specialists in neurosurgery. We:

• select clinics and experts: recommend medical centers equipped with the latest technology and experienced in treating complex tumor formations.
• provide support before and after treatment: assist with logistics, accommodation, translation of medical documentation, and provide information about rehabilitation programs.
• guarantee a personalized approach: consider the individual characteristics of the patient, their medical history, and preferences to create an optimal treatment path that is transparent and understandable at every stage.

Choosing the right therapy strategy for brain tumors is not just a medical decision but a step towards a better and more fulfilling life. Alisa Health Group is ready to help you navigate the variety of options and organize access to vetted experts whose knowledge and experience meet the highest international standards of neurosurgery.